Agilent Technologies, Inc. (NYSE:A) Stock Position Lifted by LMR Partners LLP

LMR Partners LLP increased its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 56.0% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 65,401 shares of the medical research company's stock after purchasing an additional 23,466 shares during the quarter. LMR Partners LLP's holdings in Agilent Technologies were worth $8,786,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of A. CKW Financial Group grew its holdings in shares of Agilent Technologies by 114.9% during the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company's stock worth $25,000 after buying an additional 100 shares in the last quarter. Global X Japan Co. Ltd. lifted its stake in shares of Agilent Technologies by 161.1% in the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock valued at $25,000 after purchasing an additional 116 shares in the last quarter. Redwood Park Advisors LLC acquired a new position in shares of Agilent Technologies in the 4th quarter valued at about $27,000. Lee Danner & Bass Inc. purchased a new stake in shares of Agilent Technologies during the 4th quarter worth about $29,000. Finally, Hanson & Doremus Investment Management increased its position in Agilent Technologies by 66.5% during the 4th quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company's stock worth $35,000 after purchasing an additional 105 shares in the last quarter.

Wall Street Analyst Weigh In

A has been the topic of several research reports. Jefferies Financial Group cut their price target on shares of Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a report on Monday, April 21st. TD Cowen lifted their price target on shares of Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research note on Thursday, April 10th. Wells Fargo & Company cut their price objective on shares of Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating on the stock in a report on Thursday, April 17th. Robert W. Baird lowered their target price on Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating for the company in a research note on Thursday, February 27th. Finally, Barclays cut their price target on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. Seven analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat, Agilent Technologies currently has an average rating of "Moderate Buy" and a consensus target price of $143.00.

Insider Transactions at Agilent Technologies

In other news, VP Rodney Gonsalves sold 1,908 shares of the business's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the sale, the vice president now directly owns 21,786 shares of the company's stock, valued at $2,657,456.28. The trade was a 8.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Daniel K. Podolsky sold 1,819 shares of the firm's stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the transaction, the director now owns 35,737 shares of the company's stock, valued at approximately $4,161,931.02. The trade was a 4.84% decrease in their ownership of the stock. The disclosure for this sale can be found here.

Agilent Technologies Stock Performance

Shares of A traded up $1.36 during mid-day trading on Friday, hitting $113.76. The stock had a trading volume of 1,811,948 shares, compared to its average volume of 1,901,622. The company has a market cap of $32.43 billion, a PE ratio of 26.15, a PEG ratio of 3.15 and a beta of 1.27. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $155.35. The company's fifty day simple moving average is $110.59 and its two-hundred day simple moving average is $128.32. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The firm had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. On average, equities analysts expect that Agilent Technologies, Inc. will post 5.54 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st were given a dividend of $0.248 per share. The ex-dividend date was Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.87%. Agilent Technologies's dividend payout ratio (DPR) is presently 22.76%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.